Skip to content
healthcare.dev
Get a free key

Cisatracurium Besylate

NDC 31722-313, Cisatracurium Besylate, injection, from Camber Pharmaceuticals Inc..

Product NDC
31722-313
Status
Listed
Labeler
Camber Pharmaceuticals Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212432
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-313 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CISATRACURIUM BESYLATE2 mg/mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
31722-313-103172203131010 VIAL, SINGLE-DOSE in 1 CARTON (31722-313-10) / 5 mL in 1 VIAL, SINGLE-DOSE (31722-313-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d8b5eb77-b393-4cd7-86c5-d2a9d131f96d

Use it

Look up 31722-313 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-313 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-313. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.